Trials available for breast, colon, lung and pancreatic cancers
SEDONA, Ariz. —Deborah Lindquist, MD, Arizona Oncology medical oncologist and hematologist, is serving as the principal investigator for clinical trials open to patients who require chemotherapy following breast cancer surgery. Her office is also participating in several other clinical trials for colon, lung and pancreatic cancers. These trials are being offered locally through Arizona Oncology. Because of Arizona Oncology’s affiliation with The US Oncology Network, it has access to US Oncology Research, which gives patients access to cutting-edge nationwide research and clinical trials. US Oncology Research has played a role in the development of 43 cancer-fighting drugs approved by the Food & Drug Administration (FDA).
Dr. Lindquist is currently The US Oncology Network’s research leader for Arizona Oncology’s northern Arizona sites. Current trials run by her office include:
- Two chemotherapy trials for breast cancer patients, who have just had their surgery. One is a national trial looking at whether adding either Adriamycin or Avastin adds benefit. The other trial looks at an IV drug that may be better tolerated than most chemotherapy drugs for adjuvant breast cancer treatment, in combination with an oral chemotherapy drug.
- Two trials for HER-2 positive breast cancer using a new oral agent that is not considered chemotherapy.
- Two trials using a not-yet-released biologic drug in combination with chemotherapy—one for lung cancer that has spread and another for colon cancer that has spread.
Other trials are available for pancreatic cancer patients to study ways to prevent nausea in those undergoing chemotherapy for the first time; to study results of oral treatments for chronic myelogenous leukemia; and to study any cancers for the presence of a protein on the cells, that if positive, offers another new treatment.
“Clinical trials such as these offer renewed hope to cancer patients by providing them with new treatment options, as well as intensive follow-up by our wonderful research staff,” said Dr. Lindquist. “It’s especially gratifying to be able to offer this level of comprehensive cancer care to patients right here in the Sedona area. Our patients receive the most advanced cancer treatment close to home—near their support system of family and friends.”
Dr. Lindquist is a member of the American College of Physicians, American Society of Hematology, American Society of Clinical Oncology and the American Society of Breast Disease. She received her medical degree from the University of Nebraska’s College of Medicine in Omaha and completed her residency at the University of Minnesota Hospitals followed by a fellowship in hematology and oncology at the University of Iowa Hospitals in Iowa City. Through her work with The US Oncology Network Breast Cancer Committee, she works with physicians across the country to stay current on the latest advancements and research protocols for breast cancer.
“Our practice is devoted to treating the whole patient—emotionally and physically,” said Dr. Lindquist. “We combine this with the most recent research and treatment protocols to put a plan together that meets each patient’s individual needs.”
Dr. Lindquist’s practice serves Sedona, Rim Rock, Verde Valley and surrounding areas, including patients previously cared for by Robert Rufo, MD, who recently retired. Dr. Lindquist works closely with Jody Pelusi, RN, PhD, AOCN, AONP, who has 35 years experience in advanced cancer care, as well as a specialty in genetic risk assessment. Dr. Lindquist’s practice is located at 3700 W. State Route 89A in Sedona, Ariz. For more information or to schedule an appointment, call 928-204-4163.
About Arizona Oncology
Arizona Oncology is the largest group of medical professionals in Arizona devoted exclusively to cancer care. With more than 50 practicing physicians, we serve patients at more than 24 locations throughout Arizona, including Cottonwood, Deer Valley, Flagstaff, Glendale, Green Valley, Marana, Nogales, Oro Valley, Phoenix, Prescott Valley, Safford, Scottsdale, Sedona, Sierra Vista and Tucson. We are proud to provide comprehensive, compassionate, cancer care in a patient-focused, cost effective, community-based setting. Arizona Oncology provides patients with access to the latest treatments, state-of-the-art technology and access to cutting edge nationwide research and clinical trials. We believe it is beneficial when these therapies are provided in a community setting, close to patients' home and your support system. Our physicians are supported by talented clinical staff members who are sensitive to the needs of cancer patients and their caregivers. For more information, please visit www.ArizonaOncology.com.
Arizona Oncology is united in healing with The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks focused on advancing cancer care in America. As an affiliate of The US Oncology Network, Arizona Oncology is united with more than 1,000 physicians and 10,000 cancer professionals nationwide. Arizona Oncologyparticipates in clinical trials through US Oncology Research, which has helped to develop 43 FDA approved cancer therapies.For more information, visit www.usoncology.com.
About US Oncology Research
US Oncology Research draws from a network of experienced investigators and dedicated clinical staff who specialize in Phase I through Phase IV oncology clinical trials. US Oncology Research serves more than 90 sites in more than 250 locations managing more than 200 active trials at any given time. Physicians in the research network have enrolled more than 49,600 patients in nearly 1,200 trials since inception in 1992 and have contributed to the development of 43 cancer therapies approved by the FDA. For more information call (800) 482-6700, option 4 or visit www.usoncology.com/oncologists.